Crawford Fund Management, LLC Bridge Bio Pharma, Inc. Transaction History
Crawford Fund Management, LLC
- $396 Billion
- Q2 2024
A detailed history of Crawford Fund Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Crawford Fund Management, LLC holds 20,600 shares of BBIO stock, worth $527,566. This represents 0.13% of its overall portfolio holdings.
Number of Shares
20,600Holding current value
$527,566% of portfolio
0.13%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BBIO
# of Institutions
294Shares Held
176MCall Options Held
8.64MPut Options Held
2.84M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$795 Million45.4% of portfolio
-
Viking Global Investors LP25.1MShares$643 Million2.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$360 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$319 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$155 Million67.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.8B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...